跳至主要内容
临床试验/NCT07153003
NCT07153003Enrolling By Invitation4 期

Efficacy And Safety Of Tramadol And Oxycodone Versus Oxycodone Monotherapy For Pain Control After Primary Total Knee And Total Hip Arthroplasty: A Prospective Randomized Controlled Trial

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 560 人开始时间: 2026年2月2日最近更新:
干预措施
相关药物

试验速览

阶段
4 期
状态
Enrolling By Invitation
发起方
Mayo Clinic
入组人数
560
试验地点
1
主要终点
Cumulative opioid consumption during the first 30 days

研究概览

简要总结

The purpose of this study is to evaluate the effectiveness and safety of tramadol and oxycodone therapy in comparison to oxycodone alone as part of a multimodal pain regimen to reduce postoperative opioid consumption, pain, minimize adverse events and complications for primary total knee arthroplasty (TKA) and primary total hip arthroplasty (THA).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Primary TKA
  • Primary THA
  • Age > 18 years

排除标准

  • Age < 18 years
  • Revision or partial TKA/THA
  • Pregnant or breast-feeding women
  • Simultaneous bilateral TKA/THA
  • Primary TKA/THA due to oncologic reason
  • Anaphylaxis to opioids
  • Renal or liver failure
  • Prior opioid use disorder/ substance use disorder
  • Opioid use within 3 months prior to surgery
  • Patients needing a translator and those with dementia or other cognitive deficits
  • Patients taking Monoamine Oxidase Inhibitor (MOAI) medications (phenelzine, tranylcypromine) or benzodiazepine medications (alprazolam, diazepam, lorazepam, etc)

研究组 & 干预措施

Oxycodone Only

Active Comparator

Patient's will be prescribed only Oxycodone for post operative pain management.

干预措施: Oxycodone (Drug)

Multimodal Pain Control

Active Comparator

Patients will be prescribed Tramadol and Oxycodone for post operative opioid pain relief.

干预措施: Tramadol and Oxycodone (Drug)

结局指标

主要结局

Cumulative opioid consumption during the first 30 days

时间窗: 30 days

Total amount of opioid medication taken for the first 30 days following surgery, reported in milligrams (mg)

次要结局

  • Cumulative opioid consumption during the first 90 days(90 days)
  • Postoperative opioid refills within 90 days(90 days)
  • Number of unused opioid pills(90 days)
  • Change in Visual Analogue Scale (VAS) pain scores(Daily for 90 days)
  • Number of complications(90 days)
  • Number of emesis episodes(90 days)
  • Rate of antiemetic use(90 days)
  • Satisfaction survey scores(90 days)
  • Length of Stay(Post-operatively, up to 90 days)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Charles P. Hannon

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验